These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 33180272)

  • 1. Supra-therapeutic Linezolid Trough Concentrations in Elderly Patients: A Call for Action?
    Cattaneo D; Fusi M; Cozzi V; Baldelli S; Bonini I; Gervasoni C; Clementi E
    Clin Pharmacokinet; 2021 May; 60(5):603-609. PubMed ID: 33180272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linezolid dose adjustment according to therapeutic drug monitoring helps reach the goal concentration in severe patients, and the oldest seniors benefit more.
    Xu Y; Yang X; Liang P; Qu C
    BMC Infect Dis; 2023 Nov; 23(1):840. PubMed ID: 38030977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic drug management of linezolid: a missed opportunity for clinicians?
    Cattaneo D; Gervasoni C; Cozzi V; Castoldi S; Baldelli S; Clementi E
    Int J Antimicrob Agents; 2016 Dec; 48(6):728-731. PubMed ID: 27769709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 10-Year Experience of Therapeutic Drug Monitoring (TDM) of Linezolid in a Hospital-wide Population of Patients Receiving Conventional Dosing: Is there Enough Evidence for Suggesting TDM in the Majority of Patients?
    Pea F; Cojutti PG; Baraldo M
    Basic Clin Pharmacol Toxicol; 2017 Oct; 121(4):303-308. PubMed ID: 28419737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proactive therapeutic drug monitoring (TDM) may be helpful in managing long-term treatment with linezolid safely: findings from a monocentric, prospective, open-label, interventional study.
    Cojutti PG; Merelli M; Bassetti M; Pea F
    J Antimicrob Chemother; 2019 Dec; 74(12):3588-3595. PubMed ID: 31504570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proposal of initial and maintenance dosing regimens with linezolid for renal impairment patients.
    Kawasuji H; Tsuji Y; Ogami C; Kimoto K; Ueno A; Miyajima Y; Kawago K; Sakamaki I; Yamamoto Y
    BMC Pharmacol Toxicol; 2021 Mar; 22(1):13. PubMed ID: 33663616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linezolid Dosing in Patients With Liver Cirrhosis: Standard Dosing Risk Toxicity.
    Luque S; Muñoz-Bermudez R; Echeverría-Esnal D; Sorli L; Campillo N; Martínez-Casanova J; González-Colominas E; Álvarez-Lerma F; Horcajada JP; Grau S; Roberts JA
    Ther Drug Monit; 2019 Dec; 41(6):732-739. PubMed ID: 31259884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between Increased Linezolid Plasma Concentrations and the Development of Severe Toxicity in Multidrug-Resistant Tuberculosis Treatment.
    Eimer J; Fréchet-Jachym M; Le Dû D; Caumes E; El-Helali N; Marigot-Outtandy D; Mechai F; Peytavin G; Pourcher V; Rioux C; Yazdanpanah Y; Robert J; Guglielmetti L;
    Clin Infect Dis; 2023 Feb; 76(3):e947-e956. PubMed ID: 35717636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic drug monitoring may improve safety outcomes of long-term treatment with linezolid in adult patients.
    Pea F; Viale P; Cojutti P; Del Pin B; Zamparini E; Furlanut M
    J Antimicrob Chemother; 2012 Aug; 67(8):2034-42. PubMed ID: 22553142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Research of optimal dosing regimens and therapeutic drug monitoring for vancomycin by clinical pharmacists: analysis of 7-year data].
    Xu G; Chen E; Mao E; Che Z; He J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Jul; 30(7):640-645. PubMed ID: 30045790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individualized dosing of vancomycin in geriatric patients.
    Suchánková H; Lečbychová K; Strojil J; Fürst T
    Epidemiol Mikrobiol Imunol; 2020; 69(4):172-180. PubMed ID: 33445941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematological toxicities associated with linezolid therapy in adults: key findings and clinical considerations.
    Cattaneo D; Marriott DJ; Gervasoni C
    Expert Rev Clin Pharmacol; 2023 Mar; 16(3):219-230. PubMed ID: 36787631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic drug monitoring of linezolid and exploring optimal regimens and a toxicity-related nomogram in elderly patients: a multicentre, prospective, non-interventional study.
    Liu T; Yuan Y; Wang C; Wu J; Wang Y; Na P; Chen X; Rao W; Zhao J; Wang D; Wang H; Duan Z; Xie F; Fang X; Xie L; Li H
    J Antimicrob Chemother; 2024 Jun; ():. PubMed ID: 38873816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic drug monitoring of linezolid: a retrospective monocentric analysis.
    Pea F; Furlanut M; Cojutti P; Cristini F; Zamparini E; Franceschi L; Viale P
    Antimicrob Agents Chemother; 2010 Nov; 54(11):4605-10. PubMed ID: 20733043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LInezolid Monitoring to MInimise Toxicity (LIMMIT1): A multicentre retrospective review of patients receiving linezolid therapy and the impact of therapeutic drug monitoring.
    Lau C; Marriott D; Bui J; Figtree M; Gould M; Chubaty A; Su Y; Adhikari S; Konecny P; Kozierowski K; Holland T; Milliken E; Akram A; Mcnamara A; Sun Y; Van Hal S; Patanwala AE; Shahabi-Sirjani A; Gray T; Yeo CY; Netluch A; Halena S; Appay M; Alameddine R; Yin F; Nguyen Q; So MY; Sandaradura I; Kim HY; Galimam S; Cerruto N; Lai T; Gilbey T; Daveson K; Reuter SE; Penm J; Alffenaar JW
    Int J Antimicrob Agents; 2023 May; 61(5):106783. PubMed ID: 36921808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of high plasma concentrations of linezolid in Taiwanese adult patients- therapeutic drug monitoring in improving adverse drug reactions.
    Cheng CN; Wu CC; Kuo CH; Wang CC; Wang JT; Lin YT; Jhang RS; Lin SW
    J Formos Med Assoc; 2021 Jan; 120(1 Pt 2):466-475. PubMed ID: 32600864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does the conventional dosage of linezolid necessitate therapeutic drug monitoring?-Experience from a prospective observational study.
    Fang J; Chen C; Wu Y; Zhang M; Zhang Y; Shi G; Yao Y; Chen H; Bian X
    Ann Transl Med; 2020 Apr; 8(7):493. PubMed ID: 32395537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 1 year retrospective audit of quality indicators of clinical pharmacological advice for personalized linezolid dosing: one stone for two birds?
    Pea F; Cojutti P; Dose L; Baraldo M
    Br J Clin Pharmacol; 2016 Feb; 81(2):341-8. PubMed ID: 26469887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initial trough concentration may be beneficial in preventing linezolid-induced thrombocytopenia.
    Komatsu T; Nakamura M; Uchiyama K; Inoue G; Sakanoue K; Kawamura A; Hiratsuka K; Takayama Y; Takaso M; Atsuda K
    J Chemother; 2022 Oct; 34(6):375-380. PubMed ID: 35209803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors associated with high linezolid trough plasma concentrations.
    Morata L; De la Calle C; Gómez-Cerquera JM; Manzanedo L; Casals G; Brunet M; Cobos-Trigueros N; Martínez JA; Mensa J; Soriano A
    Expert Opin Pharmacother; 2016 Jun; 17(9):1183-7. PubMed ID: 27156708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.